KeyBanc analyst Matthew Gillmor initiated coverage of HCA Healthcare with an Overweight rating and $475 price target The firm said that HCA’s success has been defined by the strategic positioning of its hospital systems, the depth of its networks, and strong management execution. There is a self-perpetuating quality to HCA’s performance, marked by superior growth and margins that generate strong cash flow, the analyst tells investors in a research note. The firm added that volume momentum appears strong and that the stock’s valuation is now higher.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HCA:
- HCA Healthcare initiated with an Overweight at KeyBanc
- HCA Healthcare initiated with an Equal Weight at Morgan Stanley
- HCA Healthcare price target raised to $405 from $378 at RBC Capital
- HCA Healthcare price target raised to $430 from $390 at Truist
- HCA Healthcare participates in a conference call hosted by Truist